CVS Health Corporation (NYSE:CVS) is one of the best large cap value stocks to buy now. Bank of America Securities analyst Allen Lutz maintained a Buy rating on CVS Health Corporation (NYSE:CVS) on September 25 and set a price target of $89.00.
CVS Health Corporation reported $98.9 billion in total revenues for fiscal Q2 2025, up 8.4% compared to the prior year period.
GAAP diluted EPS for the quarter was $0.80, and adjusted EPS was $1.81. CVS Health Corporation also generated year-to-date cash flow from operations of $6.5 billion.
CVS Health Corporation is a health solutions company that operates in four segments: healthcare benefits, health services, pharmacy & consumer wellness, and corporate/other.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
